Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.

Chapman JA, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Axelrod DE.

BMC Cancer. 2007 Sep 10;7:174.

2.

Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.

Axelrod DE, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Yuan Y, Fu Y, Chapman JA.

Cancer Inform. 2008;6:99-109. Epub 2008 Mar 1.

3.
4.
5.

Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.

White J, Levine A, Gustafson G, Wimbish K, Ingold J, Pettinga J, Matter R, Martinez A, Vicini F.

Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):791-7.

PMID:
7860390
6.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
7.

Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.

Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):249-59.

10.

Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.

Fish EB, Chapman JA, Miller NA, Link MA, Fishell E, Wright B, McCready DR, Hiraki GY, Ross TM, Hanna WM, Lickley HL.

Ann Surg Oncol. 1998 Dec;5(8):724-32.

PMID:
9869520
11.

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.

Pinder SE, Duggan C, Ellis IO, Cuzick J, Forbes JF, Bishop H, Fentiman IS, George WD; UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma In Situ (DCIS) Working Party.

Br J Cancer. 2010 Jun 29;103(1):94-100. doi: 10.1038/sj.bjc.6605718. Epub 2010 Jun 1.

12.

Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.

Kim JY, Han W, Moon HG, Park IA, Ahn SK, Kim J, Lee JW, Kim T, Kim MK, Noh DY.

Clin Breast Cancer. 2013 Oct;13(5):385-91. doi: 10.1016/j.clbc.2013.04.005. Epub 2013 Jul 17.

PMID:
23870857
13.

Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.

Dong F, Irshad H, Oh EY, Lerwill MF, Brachtel EF, Jones NC, Knoblauch NW, Montaser-Kouhsari L, Johnson NB, Rao LK, Faulkner-Jones B, Wilbur DC, Schnitt SJ, Beck AH.

PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.

14.

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

PMID:
21935747
15.

Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?

Martin-Dunlap TM, Cyr AE, Al Mushawah F, Gao F, Margenthaler JA.

J Surg Res. 2013 Sep;184(1):228-33. doi: 10.1016/j.jss.2013.03.071. Epub 2013 Apr 8.

PMID:
23688789
16.

Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.

Mariuzzi L, Mombello A, Rucco V, Morelli L, Zamò A, Thompson D, Vaught L, Bartels HG, Mariuzzi G, Bartels PH.

Adv Clin Path. 2000 Apr;4(2):87-97.

PMID:
11080789
17.
18.

AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.

Guski H, Hufnagl P, Kaufmann O, Krause M, Winzer KJ.

Anal Quant Cytol Histol. 2000 Jun;22(3):206-12.

PMID:
10872036
19.

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.

Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH 2nd, Waldman F.

J Natl Cancer Inst. 2003 Nov 19;95(22):1692-702.

PMID:
14625260
20.

Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.

Crombie N, Rampaul RS, Pinder SE, Elston CW, Robertson JF, Ellis IO.

Br J Surg. 2001 Oct;88(10):1324-9.

PMID:
11578285

Supplemental Content

Support Center